KAIST study provides first large-scale empirical analysis of dual-use research and security oversight
Peer-Reviewed Publication
Updates every hour. Last Updated: 29-Oct-2026 02:16 ET (29-Oct-2026 06:16 GMT/UTC)
A new analysis of approximately 600,000 research papers reveals structural limits to single-country security oversight of dual-use research and identifies trade-offs that policymakers face when strengthening such oversight.
KAIST (President Kwang Hyung Lee) announced today that Professor Seokbeom Kwon of the School of Business and Technology Management has published a large-scale empirical analysis examining the structural limitations of tightening security oversight on dual-use research and its potential cost to scientific progress. The study appears in Science on June 5, 2026.
- A Cambridge-led team has developed a way to engineer better vaccines that could provide broad protection from thousands of variants of viruses - such as coronaviruses or Ebola - in a single vaccine.
- This represents a fundamental new vaccine technology that could prevent future pandemics before they begin.
- The team used the technology to engineer a vaccine designed to protect against a wide range of coronaviruses, including the cause of the COVID pandemic.
- The results of the first-in-human clinical trial of this technology found it is safe and well tolerated.